Helocyte, Inc.
Biotechnology company · New York, United States
Helocyte, Inc. is a biotechnology company headquartered in New York, United States. Its earliest recorded incorporation is in 2015. It has reported private securities offerings to the US SEC, most recently $4 million sold in a notice filed in 2016.
Helocyte at a glance
What does Helocyte do?
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $4 million sold (2016).
Frequently asked questions about Helocyte
Where is Helocyte headquartered?
Helocyte, Inc. is headquartered in New York, United States.
What does Helocyte do?
Helocyte, Inc. is a biotechnology company.
When was Helocyte founded?
The earliest incorporation on record for Helocyte, Inc. is in 2015, according to public company registers.
Similar companies
- Lexeo Therapeutics, Inc.New York City, New York, United States
- MiNK Therapeutics, Inc.New York City, New York, United States
- IN8BIO, Inc.New York City, New York, United States
- Anavex Life Sciences Corp.New York City, New York, United States
- Brainstorm Cell Therapeutics Inc.New York City, New York, United States
- Bioincept LLCNew York City, New York, United States
- Protara Therapeutics, Inc.New York City, New York, United States
- Ancilia Biosciences, Inc.New York City, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences